Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 81

Similar articles for PubMed (Select 1612738)

1.

Immunoglobulin G2 confers protection against Borrelia burgdorferi infection in LSH hamsters.

Schmitz JL, Schell RF, Callister SM, Lovrich SD, Day SP, Coe JE.

Infect Immun. 1992 Jul;60(7):2677-82.

2.

Characterization of the protective antibody response to Borrelia burgdorferi in experimentally infected LSH hamsters.

Schmitz JL, Schell RF, Lovrich SD, Callister SM, Coe JE.

Infect Immun. 1991 Jun;59(6):1916-21.

3.

Depletion of complement and effects on passive transfer of resistance to infection with Borrelia burgdorferi.

Schmitz JL, Lovrich SD, Callister SM, Schell RF.

Infect Immun. 1991 Oct;59(10):3815-8.

4.

Borreliacidal activity of sera from hamsters infected with the Lyme disease spirochete.

Lovrich SD, Callister SM, Schmitz JL, Alder JD, Schell RF.

Infect Immun. 1991 Aug;59(8):2522-8.

5.

Passive immunization prevents induction of Lyme arthritis in LSH hamsters.

Schmitz JL, Schell RF, Hejka AG, England DM.

Infect Immun. 1990 Jan;58(1):144-8. Erratum in: Infect Immun 1993 Feb;61(2):791.

6.

Ability of canine Lyme disease vaccine to protect hamsters against infection with several isolates of Borrelia burgdorferi.

Jobe DA, Callister SM, Lim LC, Lovrich SD, Schell RF.

J Clin Microbiol. 1994 Mar;32(3):618-22.

7.

Characterization of the borreliacidal antibody response to Borrelia burgdorferi in humans: a serodiagnostic test.

Callister SM, Schell RF, Case KL, Lovrich SD, Day SP.

J Infect Dis. 1993 Jan;167(1):158-64.

PMID:
8418162
8.

Abilities of OspA proteins from different seroprotective groups of Borrelia burgdorferi to protect hamsters from infection.

Lovrich SD, Callister SM, DuChateau BK, Lim LC, Winfrey J, Day SP, Schell RF.

Infect Immun. 1995 Jun;63(6):2113-9.

9.

Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.

Ikushima M, Matsui K, Yamada F, Kawahashi S, Nishikawa SK.

FEMS Immunol Med Microbiol. 2000 Sep;29(1):15-21.

13.
14.

Borrelia burgdorferi infection and immunity in mice deficient in the fifth component of complement.

Bockenstedt LK, Barthold S, Deponte K, Marcantonio N, Kantor FS.

Infect Immun. 1993 May;61(5):2104-7.

15.

Development of destructive arthritis in vaccinated hamsters challenged with Borrelia burgdorferi.

Lim LC, England DM, DuChateau BK, Glowacki NJ, Creson JR, Lovrich SD, Callister SM, Jobe DA, Schell RF.

Infect Immun. 1994 Jul;62(7):2825-33.

16.

Involvement of CD4+ T lymphocytes in induction of severe destructive Lyme arthritis in inbred LSH hamsters.

Lim LC, England DM, Glowacki NJ, DuChateau BK, Schell RF.

Infect Immun. 1995 Dec;63(12):4818-25.

17.

Characterization of an immunoreactive 93-kDa core protein of Borrelia burgdorferi with a human IgG monoclonal antibody.

Volkman DJ, Luft BJ, Gorevic PD, Schultz J, Padovano L.

J Immunol. 1991 May 1;146(9):3177-82.

PMID:
2016542
18.

Protection against Borrelia burgdorferi infection in SCID mice is conferred by presensitized spleen cells and partially by B but not T cells alone.

Schaible UE, Wallich R, Kramer MD, Nerz G, Stehle T, Museteanu C, Simon MM.

Int Immunol. 1994 May;6(5):671-81.

PMID:
8080839
19.

Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.

Lovrich SD, Jobe DA, Schell RF, Callister SM.

Clin Diagn Lab Immunol. 2005 Jun;12(6):746-51. Erratum in: Clin Diagn Lab Immunol. 2005 Sep;12(9):1139.

20.

Activity of sera from patients with Lyme disease against Borrelia burgdorferi.

Pavia CS, Wormser GP, Norman GL.

Clin Infect Dis. 1997 Jul;25 Suppl 1:S25-30.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk